Day: February 27, 2023

nivolumab had potent and durable antitumor effects and a manageable security profile in advanced melanoma patients, strongly suggesting the usefulness of nivolumab for advanced melanoma and the usefulness of pretreatment serum cytokine profiles as correlates for predicting treatment efficacy. (%) unless otherwise stated. Thirteen patients remained alive at the end of the observation period and […]